Podcasts about B21

In this episode, B21's Jed Coppenger interviews Dr. Jeff Iorg, President/CEO of the SBC Executive Committee, discussing the SBC's legal cases, finances, the trustee system, the CP, and more.

In this episode, B21's Nate Akin talks with Kyle Phillip from Guidestone on pressing financial topics for pastors, such as savings, debt management, retirement planning, and being good stewards of what God provides.

Dr. Shannon Westin and her guest, Dr. Brian  Slomovitz discuss the article “Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors” recently published in the JCO and presented at the 2024 International Gynecologic Cancer Society. TRANSCRIPT The guest's disclosures can be found in the transcript.  Dr. Shannon Westin: Hello, and welcome to another episode of JCO After Hours, the podcast where we get in depth on manuscripts and literature published in the Journal of Clinical Oncology. I'm your host, Shannon Westin, gynecologic oncologist and JCO Social Media Editor by trade. I am thrilled because we are going to be talking about gynecologic cancer today. So, this is my jam. And specifically, we're going to be talking about a manuscript that's a simultaneous publication in the Journal of Clinical Oncology and presented at the Annual Meeting of the International Gynecologic Cancer Society on October 16, 2024. And this is “Pembrolizumab or Placebo, Plus Adjuvant Chemotherapy, With or Without Radiotherapy for Newly Diagnosed High Risk Endometrial Cancer: Results in Mismatch Repair Deficient Tumors.” This is affectionately the KEYNOTE-B21 trial, also known as the GOG-3053 trial and the ENGOT-en11 trial. And we are joined today by the primary author in this manuscript, Dr. Brian Slomovitz, who is the Director of Gynecologic Oncology at Mount Sinai Medical Center in Miami Beach, Florida, and the clinical trial advisor in uterine cancer for the Gynecologic Oncology Group foundation. Welcome, Brian. Dr. Brian Slomovitz: Hey, thanks, Shannon, so much. It's a pleasure to be here. And thanks for giving us the opportunity to discuss this trial. Dr. Shannon Westin: Yes, it's a great trial and I'm so excited to talk about it. And I think we'll start just because this is a broad group that listens to this podcast, they're not all GYN oncologists, experts like yourself, so can you just level set a little bit and speak a bit about the incidence and mortality of endometrial cancer overall and the recent trends in this disease? Dr. Brian Slomovitz: Yeah, sure. So, and it is nice to speak about gynecologic cancers, as we know, endometrial cancer was and still is the most common of all gynecologic cancers. The numbers are going up. Right now, there's about 65,000 to 70,000 cases each year in the US diagnosed with endometrial cancer. The numbers are going up. A lot of its obesity related, some other factors, but as the population gets less healthy, those are some of the risk factors for the disease. The thing that, however, is quite surprising is that we're seeing the deaths due to endometrial cancer going up as well, while for other diseases, we're making slow, steady steps to try to decrease the mortality we're actually seeing an increase in mortality. And the most discouraging point, Shannon, as you know is the number of deaths from endometrial cancer is going to outnumber the number of deaths from ovarian cancer if it hasn't done it already. I mean, now's the time. So, we really need to come up with better treatment strategies to everything to decrease the incidence of disease, to help with prevention, but for those poor women who are diagnosed, to come up with better treatment options so we don't have to keep this increasing trend in mortality. Dr. Shannon Westin: Absolutely. And I think some of that is related and we don't need to get on a soapbox here, but the amount of funding that goes towards research in endometrial cancer, and of course you, you have been leading the way and really trying to get a ton of trials in this space and getting our industry partners and our government partners to really support this. So really just commending you on how much you've worked on, on this area. And to that end, we've had a huge renaissance with immunotherapy and endometrial cancer, a lot of really big trials. Why don't you give the audience a rundown of where, so far, this seems to be best utilized for people with endometrial cancer? Dr. Brian Slomovitz: Thanks for that. And as you sort of alluded to, it's been a revolution, really, with immunotherapy. We started off at immunotherapy looking at microsatellite instability or the dMMR patients. What we found is similar to other disease sites in the second and third line setting that we saw good activity with the single agent checkpoints, pembrolizumab dostarlimab, that's based on the earlier KEYNOTE data and the GARNET trial. Really, a landmark study in the second line was Vicki Makker and her colleagues put pembrolizumab and lenvatinib combination for those patients with the cold tumors. Not the dMMRs or MSI Highs, but the proficient mismatch repair. And that study in a second line setting found that it was better than chemotherapy for an overall survival advantage. So right there, we know that it works in the second line setting in the dMMR population, and we got an indication in the PMR population saying that immunotherapy works in all women with endometrial cancer at some point, then we really had the groundbreaking trials. And Shannon, thank you. You are the leader on one of the four trials that happened, to DUO-E, AtTEnd, GY018 and RUBY trial, all very similar studies showing that the combination of immunotherapy with chemotherapy in the first line, metastatic or recurrent setting had a better outcome for patients than if given chemotherapy alone. That actually led to amazing things. We had three of those drugs have FDA approvals, pembrolizumab for all comers, dMMR and PMMR in the first line metastatic setting with chemotherapy; Dostarlimab, PMR, dMMR in the first line or metastatic with chemotherapy. And Shannon, in your study, I think we still have to learn a lot from your study. DUO-E, chemotherapy plus minus dostarlimab. And you also added a PARP inhib, and those patients with a PARP did better. So I'm really looking forward to your data, to the subgroup analysis to figure out which of those patients, depending on the biomarker, do better with PARP therapy. And right now, you have a dMMR FDA indication. But who knows? The future is really exciting to see- to be splitters, not lumpers. And I really want to see how that data pans out. And so that's how it came into the first and second line setting and that led us really to come up with the idea for this trial to put it into the adjuvant setting. Dr. Shannon Westin: Right. And so, I think this would be really important because we're so ingrained in this. We see this on the day to day. Can you kind of tease out a little bit what's different about those patients that would be treated in that advanced recurrent setting versus the patients that would be potentially treated in this B21 study? Dr. Brian Slomovitz: Yeah, so the first step, we demonstrated the efficacy in patients that really the treatment options were an unmet need. In the second line setting, we didn't have good treatment options. Those are the patients with measurable disease, with symptomatic disease giving immunotherapy. And not only did we see the efficacy, which was better, but we also were able to give it with limiting the side effects as seen with chemotherapy, which is nice. And then we know that the first line therapy, traditionally for endometrial cancer with carboplatin paclitaxel, response rates about 50%, progression free survival about a year, really something that we needed to improve upon. So, adding immunotherapy to the platinum backbone therapy really demonstrated an advantage. But now what we want to do is we want to see if we could prevent, in the high-risk patients, those without disease, what can we do to help prevent the disease from recurring and help patients live longer without really the need for really lifesaving types of treatments? We want to prevent it from recurring. Dr. Shannon Westin: Yeah, I think that's essential. We know that if we can sit on that prevention side and kind of invest all the time and effort that we need to upfront, that really does yield the longer survival. So why don't you just walk through the overall design of this trial, please? Dr. Brian Slomovitz: Yeah. So, this was an all-comers trial, meaning in individuals that had high risk endometrial cancer, high risk for recurrence, that included, in endometrial cancer, we have aggressive histologic subtypes, serous histologies, clear cell histologies, any stage, as long as there was some myometrial invasion. We also, for the first time, included patients looking at the molecular subclassifications. So, if there was a P53 mutation and they were stage 1 with myometrial invasion, they were included. And then in all comers, any patients with stage 3 or up to 4a disease, as long as the surgery was for a curative intent, and they had no residual disease after surgery, then they were allowed to enroll into this trial. One of the things is that this is the first time we've done an adjuvant trial this large. I think one of the reasons that helped us succeed in doing a trial like this is that we left radiation as investigator's choice, because a lot of times going into a trial like this, people feel strongly, we know our radiation oncology colleagues, rightfully so, feel that radiation could help prevent disease from coming back. And we also have the camp that says they don't need radiation. We took that question out of this study. We let investigators decide whether or not they're going to get radiation. It was for patients to get chemotherapy, who are going to normally get chemotherapy for their high-risk disease and randomize them to chemotherapy plus placebo or chemotherapy plus pembrolizumab, a PD-1 inhibitor, in order to see if we could prevent the disease from coming back. Dr. Shannon Westin: And the primary results of this study were just presented at ESMO and published in the Annals of Oncology. Can you give us just a quick overview of what that was, what they found? Dr. Brian Slomovitz: Yep. So, we enrolled 1100 patients. The primary objective of the study was to look at the ITT population, progression free survival and overall survival. And the overall study was negative. Okay, so the hazard ratio in the ITT population was 1.02, not demonstrating a benefit of adding pembrolizumab in this population. I would say disappointing, but at the same point, something that we could really learn a lot from and somewhere that we know that in the whole population, we need to come up with better strategies to help prevent recurrence of disease, better adjuvant treatment strategies. But there's also information that we learned from this trial and that we're reporting on that we're actually super excited about and we feel may be game changing. Dr. Shannon Westin: Yeah. So, let's go to that. This is the good news. Your manuscript in the JCO, thank goodness you published it here, was focused on that subset of mismatch repair deficient. So, tell us what you found. Dr. Brian Slomovitz: So, in this study, we found that the first stratification factor was dMMR versus pMMR. Now, in the pMMR group, those patients had further stratification factors, but dMMR by itself was a stratification factor. Amongst those patients that had dMMR tumors, we found the hazard ratio to be 0.31 benefiting those patients who received pembrolizumab in the adjuvant setting. Really something that when we look at the treatment studies, the GY018s, the RUBYs, the atTEnds, the DUO-Es, in a dMMR setting, we see a similar hazard ratio of 0.3, 0.4. But to get that hazard ratio, which was statistically significant, obviously, is something that we were quite pleased with and something that we felt was worthy of reporting further. I will say it was a pre-specified endpoint. We didn't allocate alpha to it. So, at the beginning, it was a pre-specified endpoint, but at the same time even though we didn't specify alpha towards that outcome, it still, we feel is clinically meaningful and can definitely add to affect the standard of care and the management of these patients. Dr. Shannon Westin: Yeah. I'm very intrigued to see what kind of people do with this. It makes sense, mechanistically, it makes sense if there was a population that was going to benefit, if not everybody does, this is the group that will. I mean, do you feel like there's enough data? What are you going to do? FDA approval aside, obviously, those kinds of things. But how do you feel about this? Is this something you're going to offer to your patients? Dr. Brian Slomovitz: The first answer is yes. I think it's something that I would like to offer my patients. As you know, we need one of two things: we either need an FDA approval or for a lot of our payers required to be in the NCCN listings. I don't serve on the committee. I have no influence on NCCN. I'm excited to see how they'll respond to not only the Annals article, but obviously in today's release of the JCO article, I hope that they'll look upon it favorably. It's a drug that we're used to giving. Pembrolizumab, we have a lot of experience with it. It's interesting. We didn't see any new safety signals, Shannon. Dr. Shannon Westin: Yeah, I was going to ask - that's great. Dr. Brian Slomovitz: There was nothing, nothing additional that we found in this trial. So, I feel that it can definitely improve the outcome of those patients, in my view, with high risk for recurrence, treating pembrolizumab in this setting. Dr. Shannon Westin: Yeah, I think it's important, of course, to look at the safety. What about quality of life? Any new findings there? Dr. Brian Slomovitz: Yeah, we did that quality of life as part of the phase 3 trial. No difference between the two arms. No difference between the two arms. When we looked at a couple of the other analyses, we found that the benefit is the same on stage 3, 4 tumors. We saw that the benefit was there as well. So, there were less patients in the stage 1, 2 group. But I think really, for all comers, for the patient population, I would definitely consider giving pembrolizumab, again, for those patients with a deficient mismatch repair. Dr. Shannon Westin: It's really exciting, and I think you mentioned some of the statistical limitations. Anything else that gives you pause about the study or things you wish you did better? I know we always like to armchair quarterback ourselves after we do these kinds of studies. Dr. Brian Slomovitz: Yeah, it's interesting. When we designed the study years ago, we used the best information we had at that time to come up with the study design, and we're happy with it, and we really don't think that we could have done it much better. I should say, this was a great partnership that we had here between the GOG, ENGOT and with sponsor Merck, Toon Van Gorp was the lead PI of the global trial. When he gave me the good opportunity to present it at the IGCS and to be the lead author on this, it was really a great partnership. And when we came up with a trial years ago, it was the best trial that we thought at that time. And based on the information now, I think it's really something that we're excited about these results, even though the overall trial was negative. Dr. Shannon Westin: Yeah, I agree with you. I think it's interesting, it's informative to think about, “Well, what would we do now or then if we knew what we knew now?” But still, you design the trial the best way you can. I think the results are super intriguing. I'm hopeful at the way they'll be reviewed. I agree I don't have any inside information about the NCCN committee, but I do hope that they'll consider the overarching data to support immunotherapy and mismatch repair deficiency and the findings of this study. And then I guess the last question I would just ask, as you're an expert here, what are you looking forward to seeing coming next in this space? What's the stuff you're intrigued about in endometrial cancer? Dr. Brian Slomovitz: I think, Shannon, you and I have talked about this for a while. I think we're getting really close to eliminating chemotherapy for some of the patients who suffer from this disease. So, I'm not sure if we'll do a follow up to this trial, but I think a logical type of follow up would be to see: what if we just took away chemotherapy altogether and we did pembro in the adjuvant setting, pembrolizumab versus chemotherapy? We don't have that trial in the adjuvant setting, but actually, we completed accrual of that trial in the recurrent setting and we're anxiously awaiting those results. That's KEYNOTE-C93, where in the dMMR population we studied pembrolizumab versus carboplatin paclitaxel. How those results may translate into this setting, I'm not sure. Right now, it's exciting what we have, but yeah. And I think future is bright for this. Just to highlight, in the two arms, there's 140 patients approximately in each arm; there were 25 recurrences in those patients who received placebo. Only eight recurrences in those that received pembrolizumab. Really, when we talk about numbers, it's really remarkable and it shows you the benefit it really had on the patients. Dr. Shannon Westin: Well, this was great. It flew by, as it always does when I'm having conversations with you. I just really want to thank you again for taking the time to share your knowledge with our listeners. Dr. Brian Slomovitz: Thanks, Shannon. Dr. Shannon Westin: And listeners. Thank you all for taking the time to hear about endometrial cancer. Again, this was “Pembrolizumab or Placebo, Plus Adjuvant Chemotherapy, With or Without Radiotherapy for Newly Diagnosed High Risk Endometrial Cancer Results in Mismatch Repair Deficient Tumors.” And this was the JCO After Hours. If you loved what you heard, please check out wherever you get your podcast to see what else we have to offer. Have an awesome day.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.        

In this episode of the Contested Ground podcast, hosts Major General (Ret'd) Dr Marcus Thompson, inaugural head of the ADF's Information Warfare Division, Phil Tarrant and Liam Garman unpack the importance of long-range strike as a deterrent and how Australia is uplifting its cyber and information warfare capabilities. MAJGEN (Ret'd) Thompson begins unpacking the benefits of establishing the ADF's Cyber Command, drawing together the cyber capabilities of each of the services and enhancing the integrated force's warfighting effects. They then examine Iran's cyber operations against the Republican Party in the US, and whether Australia and the US should consider expanding ANZUS. The trio then discuss the acquisition of the B21 to provide redundancy as Australia procures nuclear-powered submarines and the need to develop clear doctrine across the electromagnetic spectrum. Enjoy the podcast, The Contested Ground team

In this episode of the Contested Ground podcast, hosts Major General (Ret'd) Dr Marcus Thompson, inaugural head of the ADF's Information Warfare Division, Phil Tarrant and Liam Garman unpack the importance of long-range strike as a deterrent and how Australia is uplifting its cyber and information warfare capabilities. MAJGEN (Ret'd) Thompson begins unpacking the benefits of establishing the ADF's Cyber Command, drawing together the cyber capabilities of each of the services and enhancing the integrated force's warfighting effects. They then examine Iran's cyber operations against the Republican Party in the US, and whether Australia and the US should consider expanding ANZUS. The trio then discuss the acquisition of the B21 to provide redundancy as Australia procures nuclear-powered submarines and the need to develop clear doctrine across the electromagnetic spectrum. Enjoy the podcast, The Contested Ground team

In this episode, B21's Jed Coppenger leads a panel discussion with Al Mohler, Danny Akin, JD Greear, Juan Sanchez, & Clint Pressley on the most pressing topics in the SBC today. This recording originally came from B21's Morning Panel at the 2024 SBC Annual Meeting.

一、思想問題：若是給自己的人際關係打分數，會有幾分？在哪一方面的分數較低？為什麼呢？ 二、鑰節： 25:11 一句話說得合宜，就如金蘋果在銀網子裏。25:12 智慧人的勸戒，在順從的人耳中，好像金耳環和精金的妝飾。 話語有很大的力量，可以帶來很大的建造力，也可以帶來很大的破壞力。把vv.11-12連結在一起閱讀，可以說金蘋果就是智慧人的勸誡，也是在愛與真理中的提醒；而銀網子，就是順從人的耳朵，願意聆聽並且順服。當智慧的話語與順服的心合在一起，就會有美好的生命建造。 三、經文結構： 1-7 論領袖：1-3明辨、4-5用人、6-7謙遜。 8-16 爭訟之言與美言：8-10 爭競、爭訟；11-16美言與平衡－11-13美言之福、14-16實際與節制的平衡。 17-28 人際的智慧： →A17-20 錯誤的人際：17-18對鄰舍；19-20患難時。 →→B21-22 愛仇敵。 →A23-28 錯誤的人際：23-24毀謗與爭吵；25-28膽怯、誇榮。 四、結構亮光： 25-29章又回到了所羅門的箴言。 vv.1-7 論領袖。vv.1-3提到領袖要仔細察看事情，要有洞察力，明白當前的局勢，做正確的判斷。 vv.4-5提到用人的智慧，銀匠必須把銀礦中的渣滓除掉，才能夠做合適的器皿，同樣的，若是領袖身邊的人不對，所做的工作充滿了雜質，就無法成為合用的器皿。領袖要向神求分辨的智慧，把對的人放在對的位置上。 vv.6-7 則是從跟隨者的角度來詮釋，提醒人要謙遜，不要自以為尊大，不要站在尊位，因為寧可讓別人把我們請上尊位，而不要被人請下尊位，這與耶穌的教導相同。 路14:8 「你被人請去赴婚姻的筵席，不要坐在首位上，恐怕有比你尊貴的客被他請來；14:9 那請你們的人前來對你說：『讓座給這一位吧！』你就羞羞慚慚地退到末位上去了。14:10 你被請的時候，就去坐在末位上，好叫那請你的人來對你說：『朋友，請上座。』那時，你在同席的人面前就有光彩了。 vv.8-16 談到兩種言語：爭訟時的言語與美言。 vv.8-10是關於爭訟時的話語。v.8強調不要冒失急促，可能在忙亂中會出錯，而被人羞辱、攻擊，若有別人指出你的錯誤，就無地自容；v.9即便在爭論中也要有節制，不可以牽連別人，因為這樣的話語必然會傳出去，必然製造更多的問題。 vv.11-13 是美言的力量。v.11 一句正確、準確、合適的話語，就好像金蘋果與銀網子一般美麗，並能夠祝福人。 而什麼樣的話是美言呢？v.12是經驗豐富的人的勸誡、提醒與教導，v.13是忠信的使者，傳遞正確美好的訊息。美言也需要有人配合：v.12勸戒必須配合上順服的人，才能有美好的果效；v.13忠信的使者也必須有忠信的主人，才會有使人暢快的喜樂。 vv.14-16提到即便是美言，也需要有節制。 v.14 若是答應要送禮，卻只有空口說說沒有實際行動，是沒有意義的；這是商業上的做法，卻不是聖徒當有的做法。v.16 再好的讚美、美言也需要節制，若是太多，只會過飽而嘔吐。v.15當言語看似沒有功效時，也要存著忍耐的心，繼續做正確的事，至終必能發揮效果。 vv.17-28 是人際方面的智慧。 vv.17-20 是錯誤的人際：v.17 平日喜歡串門子、說是非，可能讓人生厭而恨惡，即便是好的探訪，也要適度、適量，要考量到別人的需要與方便性。v.18 更危險的是作假見證去陷害人，會嚴重傷害鄰里關係。現代的都市社會中，鄰里的距離很近，衝突很容易發生，我們要格外謹慎。 v.19 當自己身處患難時，需要找人幫助，若是找到了不可靠的人，就如同用壞牙咀嚼、用瘸腿行走，只會製造更多的麻煩與痛苦。v.20當別人身處患難時，我們如何對待就顯得更重要，若是對傷心的人唱歌，就如同冷天脫衣、傷口灑鹽一般地痛苦與殘忍。 我們如何處患難、如何幫助面對身邊處患難的人，是考驗我們的愛心與智慧的時刻。 vv.21-22 相對於vv.17-20錯誤的人際，這裡是積極用對的方式，來對待仇敵，就是加倍地愛他，這樣做會得到兩個祝福：1）炭火堆在他的頭上，代表使他覺得羞愧，進而給他悔改的機會；2）更重要的是，使我們得到神的喜悅。 這也是保羅在羅馬書提到人際相處的重要原則：羅12:20 所以，「你的仇敵若餓了，就給他吃，若渴了，就給他喝；因為你這樣行就是把炭火堆在他的頭上。」 vv.23-28 又回到了錯誤的人際：v.23 毀謗的言語好像北風生雨，帶給人風雨與寒冷；v.24嘮叨、愛爭吵的婦人會使豪宅變成墳墓；v.26義人若是退縮，就是污染的水井、混濁的泉水，失去功能，只讓人生厭。v.27 吃蜜是好的（24:13），但是過多的蜜，會使人生厭煩；同樣的，榮耀是好的，但是過度考究、追求人的掌聲，也會讓人生厭。 v.28若是自己的性情、脾氣沒有被對付，沒有被神修剪與更新，就好像沒有城牆的城市，很容易受到攻擊與傷害。 五、反省問題： 我是否有對的朋友、對的老師、對的門徒？當如何改變？ 我的言語是否有節制、有智慧，能使人得建造與暢快？當如何改變？ 這一段列出許多錯誤的人際關係，我有哪些軟弱？應如何調整？ －－－－－－－－－－－－－－－－ 講員： 貴格會合一堂 徐坤靖牧師 聖經之鑰-各卷書播放清單： https://thfc.pse.is/3epsdf 【聖經之鑰 相關資源】YouTube： https://thfc.pse.is/3cfams電子書： https://thfc.pse.is/3ccluu Powered by Firstory Hosting

Poslechněte si pokračování série kázání z knihy Filipským od Milana Kramoliše. Tentokrát byla řeč o tom, čí příklad v životě následujeme a jaký příklad dáváme druhým lidem. Filipským 3:17-21 (B21) "Bratři, následujte společně můj příklad a všímejte si těch, kdo žijí podle našeho vzoru. Mnozí totiž žijí jako nepřátelé Kristova kříže; často jsem vám o nich říkal a nyní vám to s pláčem opakuji. Jejich konec je záhuba, jejich bůh břicho a jejich sláva v jejich hanebnostech. Takoví myslí jen na pozemské věci, my ale máme občanství v nebi, odkud očekáváme Spasitele – Pána Ježíše Krista. Ten promění naše ubohé tělo do podoby jeho slavného těla, a to mocí, kterou je schopen podmanit si vše."

Omlouváme se za šum v nahrávce, došlo k chybě při nahrávání. Další epizody už by měly být bez šumu. Jak může příběh 'Štědrého krále' proměnit náš pohled na nedostatek a hojnost? V neděli jsme s Bedřichem Smolou četli podobenství v 19. kapitole Lukášova evangelia, poslechněte si záznam. Lukáš 19:11-27 (B21) "Tehdy vyprávěl svým posluchačům další podobenství, protože se blížil k Jeruzalému a oni si mysleli, že se už nyní má zjevit Boží království. Řekl jim: „Jeden urozený člověk odešel do daleké země, aby se odtamtud vrátil jako král. Předtím si zavolal deset svých služebníků, dal jim deset hřiven a řekl jim: ‚Hospodařte s tím, dokud nepřijdu.‘ Jeho krajané ho ale nenáviděli a hned vyslali poselstvo, aby vyřídilo: ‚Nechceme ho za krále!‘ Když se pak vrátil jako král, zavolal si služebníky, kterým svěřil peníze, aby zjistil, kolik kdo vydělal. Přišel první a řekl: ‚Pane, tvá hřivna vynesla deset hřiven.‘ Král odpověděl: ‚Výborně, můj dobrý služebníku! Protože jsi byl věrný v tom nejmenším, vládni deseti městům.‘ Přišel druhý a řekl: ‚Pane, tvá hřivna vydělala pět hřiven.‘ Odpověděl mu: ‚Ty buď vládcem pěti měst.‘ Potom přišel další a řekl: ‚Pane, zde máš svou hřivnu. Měl jsem ji uloženou v šátku, neboť jsem se tě bál. Jsi přísný člověk; vybíráš, co sis neuložil, a sklízíš, co jsi nezasel.‘ Král mu řekl: ‚Soudím tě podle tvých vlastních slov, zlý služebníku. Věděl jsi, že jsem přísný člověk, že vybírám, co jsem neuložil, a sklízím, co jsem nezasel? Proč jsi tedy nedal mé peníze směnárníkům, abych si je po návratu vybral i s úroky?‘ Tehdy řekl své družině: ‚Vezměte mu tu hřivnu a dejte ji tomu, který má deset hřiven.‘ ‚Pane,‘ namítli, vždyť už má deset hřiven.‘ Říkám vám: ‚Každému, kdo má, bude dáno, ale tomu, kdo nemá, bude vzato i to, co má. A ty mé nepřátele, kteří nechtěli, abych byl jejich králem, přiveďte sem a pobijte je přede mnou.‘“

Hi leuk dat je luistert naar de vijfde aflevering van Have a Good Run, op weg naar Berlijn. Ik ben Annemerel, in een vorig leven schreef ik drie boeken over hardlopen en liep ik 12 marathons. Inmiddels ben ik moeder van een peuter en een baby en hoop ik - na zes jaar afwezigheid op de marathon - in Berlijn mijn dertiende marathon te lopen. Dat doe ik niet alleen, mijn zusje Roosmarijn staat als het goed is ook aan de start van de Berlijn Marathon. Het wordt haar aller eerste marathon. In deze podcast delen we onze weg naar Berlijn, de hobbels en de bobbels, maar zeker ook de dingen die juist wel goed gaan. Wij zitten er klaar voor, jullie hopelijk ook, let's go! Shownotes Wetenschappelijke artikelen die Roos (o.a.) heeft gebruikt: - Cooldown stretches hebben geen positief effect: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.677581/full - Stretchen (vooraf) heeft vooral effect op de running economy en op de perceptie hoe de run ervaren wordt. https://www.mdpi.com/1660-4601/18/16/8386#B21-ijerph-18-08386 -Het effect van een generieke warming up (warmlopen) + dynamic stretching heeft een negatief effect op de prestatie tov alleen warmlopen https://www.tandfonline.com/doi/full/10.1080/02701367.2019.1630700

00:00 - We are a functional 1001:33 - Ricky is Bhangraman02:27 - Gateway people were wedding videographers 03:49 - Live Bhangra + unwritten gentleman's agreement 05:05 - Handsworth was the hub of Bhangra07:17 - Big artists don't do interviews anymore09:26 - Is the industry big enough for someone to get canceled?14:11 - People forget how big Jazzy B and B21 were17:51 - Is the UK just another market today? 21:17 - What is the future of bhangra music with AI?22:49 - Lack of Punjabi being spoken is impacting how people interpret songs26:09 - Do Punjabi artists choose money over strategy?28:11 - Is Bhangra run by producers rather than singers?31:02 - Evolution of bhangra turning into a views game34:07 - The highs are coming fast but the lows might come faster36:19 - Needing to buy views for Podcasts36:56 - Raf Saperra a hope for UK bhangra + needing a rival in the business38:32 - Podcast rivalry39:44 - Are comments and views skewing metrics for success?42:55 - Is the Brown Podcasting Scene running out of steam?46:13 - Need to encourage people to try + have open conversations49:00 - Do you want to be controversial to get clicks?52:24 - Getting recognised and feeling awkward55:12 - Why do you do what you do?59:52 - Lip Syncing on stage + vocal quality01:04:54 - Ricky + Indy are dukhi bundeh + Diljit brought the Moon01:07:54 - Why did Desi Frenzy blow up in the scene?01:11:14 - Primark + The Guardian + The Birmingham Flag01:12:59 - Sidhu Moose Wala + Kuldeep Manak + PMC01:18:52 - Manak is the G.O.A.T Follow The Bhandwagon Podcast on: YouTube - https://www.youtube.com/channel/UChze0m2rvMrznjRvxjdpAdQInsta - https://www.instagram.com/bhandwagon Follow Us On: Tik Tok - https://bit.ly/indy-and-dr-tik-tokInstagram - http://bit.ly/indy-and-dr-instaFacebook - http://bit.ly/indy-and-dr-facebookSpotify - http://bit.ly/indy-and-dr Also available at all podcasting outlets.

Poslechněte si druhé pokračování série "Nový začátek" z knihy Efezským od Bedřicha Smoly. Proč dává autor dopisu takový důraz na jednotu církve? Jak by měla jednota mezi křesťany vypadat? Jak by se k sobě měli chovat lidé v církvi, přestože jsou často velmi odlišní? Efezským 4:1-16 (B21) "Jako vězeň v Pánu vás tedy prosím, abyste svým životem dělali čest tomu povolání, které jste přijali. Buďte vždy pokorní a mírní, trpělivě se navzájem snášejte v lásce a usilujte zachovávat jednotu Ducha, spojeni poutem pokoje. Je jedno tělo a jeden Duch, jedna naděje, k níž jsme byli povoláni, jeden Pán, jedna víra, jeden křest, jeden Bůh a Otec všech, který je nade všechny a skrze všechny a ve všech. Každému jednotlivému z nás byla dána milost podle míry Kristova obdarování. Písmo přece říká: „Vystoupil do výšin, zmocnil se zajatých, dary lidem rozdělil.“ To, že „vystoupil“, musí znamenat, že předtím také sestoupil dolů na zem. Ten, který sestoupil, je právě ten, který vystoupil vysoko nad všechna nebesa, aby naplnil všechno. To on rozdal své dary – apoštoly, proroky, evangelisty, pastýře a učitele – pro přípravu svatých k dílu služby, aby se Kristovo tělo budovalo, abychom nakonec všichni dospěli k jednotě víry a poznání Božího Syna, k dokonalému lidství, k plné míře Kristovy dospělosti. Nesmíme proto nadále zůstat nemluvňaty zmítanými a unášenými kdejakým poryvem učení, lidskou prohnaností a vychytralým sváděním k bludu. Místo toho máme mluvit pravdu v lásce a v každém ohledu růst v Krista, který je hlavou. Z něj celé tělo, spojené a svázané pomocí všech tkání, roste a buduje se v lásce, když každá jednotlivá část plní úkol, který jí náleží."

Poslechněte si kázání Bedřicha Smoly z první adventní neděle roku 2023. Řeč byla o žalmu 40, který na první pohled nemá s adventem mnoho společného. Nicméně, Bedřich mluvil o očekáváních-téma společné pro advent i čtyřicátý žalm. V podcastu zmiňuje Bedřich v čase asi 2:30 píseň od kapely U2. Vystřihli jsme ji ze záznamu s ohledem na autorská práva. Píseň si můžete poslechnout ⁠zde⁠ (v čase 4:49-7:06). Žalm 40:1-12 (B21) "Pro předního zpěváka. Žalm Davidův. Na Hospodina jsem čekal toužebně a on se naklonil a uslyšel můj křik. Z vlhké jámy vytáhl mě, z kalné bažiny, mé nohy postavil na pevné skále, mé kroky upevnil. Do úst mi vložil novou píseň, chvalozpěv Bohu našemu; mnozí to spatří a budou ho mít v úctě, na Hospodina se spolehnou. Blaze člověku, který v Hospodina skládá naději, který se neobrací k pyšným ani k těm, kdo se řídí lží. Kolik jen, Hospodine Bože můj, kolik jen činíš zázraků! V úmyslech, které o nás máš, se tobě nikdo nerovná! Chtěl bych je vypovědět, o nich promluvit, je jich však víc, než dá se vypočíst! Oběti a dary sis neoblíbil, ale uši jsi mi otevřel: Nechtěl jsi oběti za hřích ani zápaly! Tehdy jsem řekl: „Hle, přicházím, jako je o mně v Knize napsáno. Mou radostí je konat vůli tvou, tvůj Zákon, Bože můj, v nitru nosím si.“ Ve velikém shromáždění jsem spravedlnost zvěstoval, své rty jsem nezdržoval, to víš, Hospodine, sám. Tvoji spravedlnost v srdci neskryl jsem, o tvé věrnosti jsem mluvil a o spáse, před velikým shromážděním jsem tvou lásku a věrnost netajil. Své slitování, Hospodine, mi prosím neodpírej; kéž láska a pravda tvá vždycky nade mnou drží stráž!

一、思想問題：基督徒在遭遇各種惡人的攻擊時，可以咒詛人嗎？ 二、鑰節： 109:28 任憑他們咒罵，惟願你賜福；他們幾時起來就必蒙羞，你的僕人卻要歡喜。 神要在我們的苦難中，做顛覆性的工作，敵人有許多咒罵、言語攻擊，但是神要賜福於我們，甚至是使用這些咒詛的聲音，來彰顯神祝福的奇妙！惡人有短暫的發達、成功，但是終久必定蒙羞；而神的僕人卻要終久歡樂，因為我們的喜樂是在神裡面。 三、經文結構： A1-20 求神刑罰惡人。 a1-5 惡人的惡行：詭詐口、撒謊舌，圍繞攻擊，以惡報善。 →b6-15 願神刑罰惡人：6-8個人遭禍－敵人受審短壽；9-13 子孫遭禍－孤兒討食躲債絕子絕孫；14-15 罪無可赦。 →→c16-20 言語：咒罵回到他身上。 B21-31 求神拯救義人。 a21-25 義人的苦情：困苦受傷、將亡瘦弱、羞辱。 →b26-29 求神拯救：人咒罵神賜福，人蒙羞我歡喜。 →→c30-31 言語：讚美神的拯救。 四、結構亮光： 本篇是大衛的咒詛詩，他咒詛敵人，求神刑罰惡人，且相信神會拯救義人。其結構有AB兩大段落：A的部分，vv.1-20求神刑罰惡人；B的部分，vv.21-31求神拯救義人。而其中都採abc的架構，a是惡人與義人的對比，即惡人的惡行與義人的苦情；b是神刑罰與拯救的對比；c是言語的對比，即咒罵與讚美。 A的部分： v.1 即便在敵人攻擊下，大衛仍然宣告神是他所讚美的神，在面對苦毒、承受苦毒攻擊中，卻仍有讚美的心，這是大衛值得我們學習之處；這也與vv.30-31的讚美作頭尾的呼應。 a的部分： vv.2-5惡人的惡行主要在言語：詭詐、撒謊、怨恨。v.4,5兩次強調敵人以惡報善，可見是大衛很親近的人起來攻擊他，有時我們最愛的人，也會是傷我們最深的人。 b的部分： vv.6-15是咒詛，宣告神對惡人的刑罰。vv.6-8是對惡人個人的刑罰，過去他攻擊人，如今他被人控告、定罪，年日短少，所累積的財寶都歸給別人；vv.9-13是惡人子孫遭禍，成為孤兒、討飯的，被趕出來、絕子絕孫、名字被塗抹。 c的部分：vv.16-20特別提到言語，當惡人咒罵，就有不止息的咒罵臨到。 神對惡人公義的刑罰：v.17他喜歡咒罵，就承受咒罵；不愛福樂，福樂就遠離；v.20,29他當義人的對頭，不斷攻擊義人，v.6而神就興起對頭來攻擊他；v.7惡人也禱告，但是被神厭惡， v.4但義人禱告卻被神悅納。 咒詛是呼求神的公義，表面看來有些過於激烈，但是新約提醒我們：羅12:14只要祝福，不可咒詛。我們對按著神形象所創造的「人」只能祝福，即便是惡人也期待他能真正悔改。我們可以禱告讓人經歷苦難，使他真正悔改抓住神，並且可以對撒但惡者的工作做這樣咒詛的禱告，v.6對頭原文就有撒但的意思。 B的部分： vv.21-31是求神拯救義人。v.21,26求神照著神的慈愛來拯救、恩待與幫助。 a的部分：vv.22-25提到了自己的苦情：受傷、將亡、軟弱、羞辱。 b的部分：vv.26-30則是神的拯救，v.28神把敵人的咒罵變成福氣，敵人必蒙羞，我們必歡喜。 c的部分：vv.30要起來讚美神，呼應了v.1的讚美。v.31提到了神站在右邊，可與v.6作對比，這兩節站在右邊、審判，這是法庭上控告者的位置，而如今卻是神在那裡為我們伸冤，這是何等恩典。 五、反省問題： 新約的聖徒不能咒詛，我們當如何為敵人惡人禱告？ 我的生活中是否被人控告，被撒旦控告，以及自我控告？我們如何經歷v.31的恩典？ －－－－－－－－－－－－－－－－ 講員： 貴格會合一堂 徐坤靖牧師 聖經之鑰-各卷書播放清單： https://thfc.pse.is/3epsdf 【聖經之鑰 相關資源】YouTube： https://thfc.pse.is/3cfams電子書： https://thfc.pse.is/3ccluu Powered by Firstory Hosting

Poslechněte si další kázání Bedřicha Smoly na příběh krále Davida. Tentokrát je řeč o Davidovu synu Abšalomovi. Jaký konflikt vznikl mezi ním a králem Davidem? Bedřich mluví o tom, že naše rozhodnutí mají různé důsledky, které musíme nést. Jak máme přistupovat k lidem, které si v životě nesou negativní důsledky a zároveň si za to mohou sami? 2. Samuelova 12:10-11 (B21) "Proto, že jsi mnou pohrdl (říká Bůh Davidovi) a vzal sis za ženu manželku Uriáše Chetejského, se od tvého domu od nynějška nikdy neodvrátí meč. Tak praví Hospodin: Hle, vzbudím proti tobě zlo z tvého vlastního domu." 2. Samuelova 13.-18. kapitola Příběh Davida a Abšaloma je zaznamenaný v uvedených kapitolách. Celý text se nám do popisku nevejde, můžete si příběh přečíst ve své Bibli/online.

Kde je Bůh když ho zrovna potřebujeme? Poslechněte si kázání Jany Dvořáčkové s názvem “Co na to Bůh?". Exodus 1:10-22 (B21) "Pojďme si rozmyslet, co s nimi, aby se nerozmnožili ještě více! Kdyby vypukla válka, mohli by se přidat k našim nepřátelům a odejít ze země!“ Ustanovili tedy nad nimi dozorce, aby je utiskovali robotou, a izraelský lid pro faraona vystavěl zásobovací města Pitom a Rameses. Čím více jej však utiskovali, tím více rostl a tím více se rozmáhal. Egypťany jímala z Izraelitů hrůza, a tak je začali nemilosrdně zotročovat. Ztrpčovali jim život těžkou dřinou s hliněnými cihlami i všemožnou dřinou na poli. Do vší té dřiny je nemilosrdně nutili. Egyptský král tehdy řekl hebrejským porodním bábám (z nichž jedna se jmenovala Šifra a druhá Pua): „Až budete Hebrejkám pomáhat při porodu, dávejte pozor, jakého jsou pohlaví: když to bude syn, zabijte ho, když to bude dcera, nechte ji žít.“ Ty porodní báby se ale bály Boha, a tak nejednaly, jak jim řekl egyptský král, a nechávaly chlapce naživu. Egyptský král si ty porodní báby dal předvolat. „Co to provádíte?“ láteřil. „Necháváte chlapce naživu!“ Porodní báby faraonovi odpověděly: „Hebrejky nejsou jako egyptské ženy – kypí životem! Než k nim porodní bába dorazí, už mají po porodu.“ Bůh pak ty porodní báby odměnil a lid se množil a velmi se rozmáhal. A že se ty porodní báby bály Boha, dal jim rodiny. Farao nakonec přikázal všemu svému lidu: „Každého syna, který se Hebrejům narodí, hoďte do Nilu; každou dceru můžete nechat žít!“ Exodus 5:4-9 (B21) "Egyptský král ale vykřikl: „Mojžíši a Árone, proč odvádíte lid od práce? Zpátky k vašim robotám!“ Farao pokračoval: „Jen se podívejte, jak se ta cháska v zemi rozmnožila – a vy je chcete zdržovat od roboty?!“ Ještě týž den farao přikázal biřicům a dozorcům lidu: „Nedávejte už jim k výrobě cihel slámu jako dosud. Ať si ji jdou sbírat sami! Požadujte ale od nich stejné množství cihel, jako vyráběli dosud. Nic jim neslevujte, vždyť zahálejí. To proto vykřikují: ‚Pojďme obětovat našemu Bohu!‘ Zavalte ty mužské dřinou, ať mají co dělat a přestanou poslouchat báchorky!“ Exodus 14:13 (B21) "Mojžíš lidu odpověděl: „Nebojte se! Zůstaňte stát a dívejte se, jak vás dnes Hospodin zachrání.” Exodus 15:14-16 (B21) "Národy roztřesou se, až to uslyší, filištínský lid úzkost zachvátí. Tehdy se zhrozí kmeny edomské, moábských siláků se zmocní děs, všichni obyvatelé Kanaánu už se potácí! Hrůza a strach je přepadne, pro velikost paže tvé zmlknou jak kámen, než přejde tvůj lid, Hospodine, než přejde lid, jejž sis vytvořil."

Join Carlos, Nev, Armando, Nik and Andy for this weeks packed show! In this week's show.... we've got some misbehaving bizjets, a new airline, an Airbus scratching it's bottom, and we look back at Concorde, on the 20th anniversary of its retirement.   In the military we've got more tanker news, B21 taxi tests, and a farewell to the Gazelle.   You can get in touch with us all at : WhatsApp +44 757 22 491 66 Email podcast@planetalkinguk.com or comment in our chatroom on YouTube.

Bohabojná Marta, punkerka Marie a novozákonní sociální revoluce. Patří ženy do kuchyně, na kazatelnu nebo do Bílého domu? Poslechněte si kázání Kláry Helánové. Lukáš 10:38-42 (B21) "Cestou přišel do jedné vesnice, kde ho k sobě přijala jistá žena jménem Marta. Její sestra Marie se posadila k Pánovým nohám a poslouchala jeho slova. Marta však byla zaneprázdněna spoustou práce. Nakonec za ním přišla a řekla: „Pane, tebe nezajímá, že má sestra nechala všechnu práci na mně? Řekni jí přece, ať mi pomůže!“ Pán jí odpověděl: „Marto, Marto, staráš se a trápíš se mnoha věcmi. Jen jedno je však potřeba. Marie si vybrala správně a to jí nikdo nevezme.“

Jak se zachovat ve vztahu k Bohu, když se nám dějí zlé věci? Poslechněte si kázání, které připravil Honza Panovský. Job 2:9 (B21) "Ještě se držíš té své bezúhonnosti? Zlořeč Bohu a zemři! Job 2:10 (B21) "Budeme snad od Boha přijímat jen dobré, a zlé ne?" Job 3:3-26 (B21)-úryvky "Zahynout měl den, kdy jsem se narodil, i noc, kdy řekli: Chlapce jsme počali! Ach ta noc – kéž byla neplodná, radostný výkřik poznat neměla! Své lůno přede mnou měla uzavřít, mé oči ušetřit všeho trápení. Proč jsem už v lůnu nezhynul? Proč jsem nezemřel při porodu? Proč tu byl klín, jenž mě přitulil? Proč prsy, z nichž jsem pil? Proč jsem jak potrat nebyl zahrabán, jako nemluvně, jež světlo nevídá? K čemu je dáno světlo ubohým a život zatrpklým; těm, kteří na smrt marně čekají, ač ji hledají víc než poklady. Mým denním chlebem je teď jen sténání, můj nářek proudí jako potoky. Stalo se mi to, čeho jsem se bál, potkalo mě to, z čeho jsem měl strach! Nemám pokoj, nemám klid, nemám odpočinutí. Přišlo trápení." Job 32:6-10 (B21) "Já jsem jen mladík a vy jste kmeti, proto jsem byl dosud nesmělý, bál jsem se říci vám své mínění. Říkal jsem si: Ať mluví starší, dříve narození ať učí moudrosti. Vše ale na duchu v člověku záleží, dech Všemohoucího dává chápání. Dříve narození nejsou vždycky moudřejší, starší nemusejí mít nejlepší úsudky. A proto říkám: Naslouchejte mi, teď zas já vyslovím své mínění." Efezským 5:20 (B21) "Vždycky za všechno děkujte Bohu a Otci ve jménu našeho Pána Ježíše Krista" 1. Tesalonickým 5:18 (B21) "Za všech okolností buďte vděční, neboť to je Boží vůle pro vás v Kristu Ježíši"

Poslechněte si další kázání Bedřich Smoly ze série “Imagine”, což se dá do češtiny přeložit jako Představte si... V této sérii mluvíme o podobenstvích - jsou to příběhy, pomocí kterých Ježíš ilustruje principy nebo hodnoty, na kterých mu záleží. Co chce, abychom si představili, když vypráví příběh o čtyřech půdách? Lukáš 8:4-18 (B21) "Když se začal scházet veliký zástup (neboť lidé z jednotlivých měst proudili za ním), promluvil v podobenství: „Vyšel rozsévač, aby rozséval své zrno. A jak rozséval, jedno padlo podél cesty, bylo pošlapáno a sezobali je ptáci. Jiné padlo na skálu, a když vzešlo, uschlo, protože nemělo vláhu. Další padlo mezi trní a to rostlo spolu s ním, až je udusilo. Jiné však padlo do dobré země, a když vzešlo, přineslo stonásobnou úrodu. "Když to dořekl, zvolal: „Kdo má uši k slyšení, slyš!“ Učedníci se ho ptali, co je to za podobenství. Řekl jim: „Vám je dáno znát tajemství Božího království, k ostatním ale mluvím v podobenstvích, aby hleděli, ale neviděli a slyšeli, ale nerozuměli. Zrno v tom podobenství je Boží slovo. Ti podél cesty jsou ti, kteří slyší, ale potom přichází ďábel a bere jim Slovo ze srdce, aby neuvěřili a nebyli spaseni. Ti na skále jsou ti, kteří slyší Slovo a s radostí je přijímají, ale nemají kořeny. Ti věří jen dočasně, v době pokušení odpadají. Zrno, které zapadlo mezi trní, jsou ti, kteří slyšeli, ale pozvolna bývají dušeni starostmi, bohatstvím a rozkošemi tohoto života, takže nedozrají, aby nesli ovoce. Zrno v dobré zemi jsou ale ti, kteří slyší Slovo, chovají je v ušlechtilém a dobrém srdci a vytrvale přinášejí užitek. Nikdo nerozsvítí lampu, aby ji přikryl nádobou nebo postavil pod postel. Postaví ji na svícen, aby příchozí viděli světlo. Není totiž nic tajného, co nebude zjeveno, ani nic skrytého, co nebude poznáno a nevyjde najevo. Proto dávejte pozor na to, jak posloucháte. Tomu, kdo má, totiž bude dáno, ale tomu, kdo nemá, bude vzato i to, co si myslí, že má.“

一、思想問題：當我們回顧自己的過去、家族的歷史、國家的歷史，我們看到了什麼？又與今天的我們有什麼關係？ 二、鑰節： 78:6 使將要生的後代子孫可以曉得；他們也要起來告訴他們的子孫，78:7 好叫他們仰望神，不忘記神的作為，惟要守他的命令。 信仰不是只有我們這一代，而是要去思想一代又一代的信仰傳承，要教導孩子如何使人認識神的愛，如何與人分享神的愛。我們所經歷的一切，為的是使我們經歷神作為的奇妙，使我們絕對不忘記神，並且堅持要遵行神的話。 三、經文結構： 1-7 教導後代不忘記神。 A8-11 列祖的悖逆：不守神的約、忘記神。 →B12-16 神的恩典：紅海分開出埃及、磐石出水。 A17-20 列祖的悖逆：得罪神、試探神，隨己所欲求食物，妄論神。 →B21-33 神發怒刑罰：21-22因人的不信；23-29賜下嗎哪、降肉如雨；30-33 在吃飽時犯罪，神擊殺。 A34-37 列祖的悖逆：34-35 短暫悔改、回轉尋求神；36-37 心不正、不忠。 →B38-39 神的恩典：憐憫不滅絕。 A40-42 列祖的悖逆：試探神，使神擔憂。 →B43-55 神的恩典：43-51十災、擊殺埃及人長子；52-55 神恩待選民，帶領進迦南地，趕出外邦人。 A56-58 列祖的悖逆：邱壇、拜偶像。 →B59-72 神的恩典：59-64 離棄約櫃，百姓被擄、被殺；65-72 神刑罰敵人，揀選、引導猶大。 四、結構亮光： 本篇詩篇回顧過去以色列的歷史，是由人的悖逆與神的恩典兩條線交錯來描述，A是列祖的悖逆，B是神的恩典。ABAB的架構共出現了5次，可見人一再悖逆，而神卻一再施恩。若亞薩的詩是被擄後的詩歌，這就更具有豐富的意義，提醒我們今日要如何在被擄中趕快悔改、抓住神。 vv.1-7是重要的引言，也是本篇的目的，要向後代述說神的作為。v.7提到好使子孫永遠不忘記神的作為，並要遵守神的命令。信仰的傳承是每一代的任務，我們期待留給孩子與家族的是什麼，關鍵就在於今日我們所看重的，與要傳遞的到底是什麼！ A的部分，經文中提到的悖逆： vv.8-11 是第一段，v.8心不正、心不誠實；v.9提到以法蓮，v.67再次提到，以分裂王國最大的支派作代表，表示拒絕神的揀選，也可說是指士20章的事件──不守神的約。 vv.17-20是第二段，即便曠野有水，人仍然悖逆神，挑戰、妄論神，抨擊神說祢能變個把戲，把肉變出來，為我們在曠野開派對嗎？ vv.34-37是第三段，即便vv.34-35看起來在管教後有求問神、尋求神、追念神，但只是膚淺、短暫、沒有深度的悔改，因為vv.36-37他們的心仍是悖逆的，一切的誓言、委身都是在諂媚、說謊，其關鍵在於v.8,37心不正。 vv.40-42是第四段，在曠野悖逆、再三試探神、懷疑神。v.42忘記神，不追念神的能力，這也是本篇詩篇寫作的目的，v.7期待人們子子孫孫都能不要忘記神的作為！ vv.56-58是第五段的悖逆，他們試探、悖逆至高主。v.57翻背的弓，表示他們像一把鬆弛的弓般地不可靠，如同v.9所提到的一樣。v.58邱壇與偶像也充斥在選民中間。 B的部分： 但是經文中更寶貴的是，即便人這樣的悖逆、軟弱，但是神仍用不動搖的愛與管教來對待我們。 vv.12-16是第一段的恩典，神仍然在埃及行奇事，使紅海分開，雲柱火柱圍繞，使磐石出水。 vv.21-33是第二段，即便是神發怒管教，仍是為了要使選民得著救恩。v.21過去怒氣臨到外邦人，今日也臨到神的選民，最可怕的是vv.23-29表面上是神的恩典，在曠野中有肉可以吃，給他們超乎想像的祝福，但是背後卻是神的刑罰，v.30當肉還在口中，神就刑罰、擊打以色列人，殺了那吃最多的肥壯人。不要以為今天一帆風順，就代表神悅納我們，我們也可能正在積蓄神的憤怒，這可能只是表面的恩典，是刑罰的象徵，而最大的刑罰就是失去永生，因此許多人今生的富足，其實是對他們最大的刑罰，因為自以為安全，就安安逸逸地下陰間。 vv.38-39是第三段的恩典，v.21剛剛講到神對選民發怒，在這裡神就屢次消怒，憐恤人只是血氣、如風一般。 vv.43-55是第四段的恩典，重述了埃及的十災，而vv.52-55神對選民卻是更大的恩典，把外邦人趕出，使選民住在其中。 vv.59-72是第五段的恩典，vv.59-64神發怒離開示羅、離開聖所、離開約櫃，但就在被擄、可怕的光景中，v.65神仍然在工作，打退敵人、揀選猶大、重新堅立與猶大的約。神使地上的君王重新有純正的品格，與巧妙的恩賜來引導百姓，這更可說是彌賽亞的預言。 五、反省問題： 我是否常常忘記神、悖逆神、不守神的約，只有短暫而沒有深度的悔改？ 我今日的平順是神祝福的記號，還是神要審判刑罰的前兆？我確定正走在神的道路上嗎？ 我們幾次犯罪，神就幾次憐憫，這給我們什麼安慰與鼓勵？ －－－－－－－－－－－－－－－－ 講員： 貴格會合一堂 徐坤靖牧師 聖經之鑰-各卷書播放清單： https://thfc.pse.is/3epsdf 【聖經之鑰 相關資源】YouTube： https://thfc.pse.is/3cfams電子書： https://thfc.pse.is/3ccluu Powered by Firstory Hosting

O espectáculo de dança “Relative World”, que está no Festival Off Avignon até 27 de Julho, conta uma história de “amor em mundos paralelos”. O resumo é feito pela bailarina portuguesa Aline Lopes que contracena com Kim Evin na peça encenada por Manon Contrino e Toufik Maadi. Em palco, Aline Lopes e Kim Evin dançam o luto, lutam pela reunião, gritam saudade e criam um espaço para reinventar uma vida onde a morte aconteceu. RFI: O que conta o espectáculo “Relative World”?Aline Lopes, Bailarina: Este espectáculo é sobre um dueto de amor em mundos paralelos. Já vivemos num mundo juntos, mas separámo-nos. Em cada mundo, há uma fisicalidade diferente e há uma emoção diferente e estamos sempre na luta de nos encontrarmos e, no fim, acabamos por nos encontrar.O que significa o título do espectáculo, “mundo relativo” [“Relative World”?]Porque precisamente estes mundos paralelos fazem com que, no final, o mundo em que nós estamos seja relativo porque o que importa é nós estarmos juntos e não importa o mundo onde nós estivermos. É o atravessar que importa, o caminhar que importa.A história fala de dois corpos e duas almas que vivem em dois mundos, o do vivo e o dos mortos, mas que através da dança se encontram e enfrentam o tempo, a morte e o amor. Como é que pela dança conseguem passar essa mensagem? Eu acho que, como em cada criação, o bailarino deve procurar em si as emoções que ele vive e os episódios que ele vive. Já me aconteceu perder alguém. Eu até falo no espectáculo, numa das músicas, que é a minha avó. Então eu apoio-me nessa emoção para ir procurar isso em mim e para tentar passar às pessoas para que elas também possam ir procurar essa emoção profunda nelas.Isso vê-se no espectáculo. A Aline é muito expressiva, não só com o corpo mas notam-se as emoções no seu rosto. Nota-se que está a sentir mesmo aquilo que está a dançar...Sim. Nunca me tinha acontecido. Nós entramos e saímos várias vezes do palco e nunca me tinha acontecido sentir uma enorme vontade de chorar às vezes quando saio porque a emoção é mesmo muito forte. Eles também procuraram isso porque o coreógrafo teve um acidente vascular e foi um episódio muito trágico e quando eles começaram a criação eles não procuraram logo fazer isso, mas foi no inconsciente deles que a peça começou a criar-se.Ou seja, neste caso a dança, a música, aquilo que vocês levam para o palco, ajudam a ultrapassar qualquer coisa, a fazer um luto...Exacto, no fim é aquela alegria de que OK eu continuo cá, eu apoio-me nas coisas boas que estão cá porque são muitas. Temos muitas coisas a que ser gratos e no fim é isso que eu, pelo menos, vivo na peça e que vivo também na minha vida independentemente das dificuldades, vamos lá.Como é que trabalharam as coreografias para alcançar esta imagem da dança que ultrapassa os impossíveis?Eles gostam muito de trabalhar a partir da improvisação. Com esta peça eles tinham já algumas ideias de objectos que eles nos queriam fazer trabalhar. Punham em disposição no estúdio. “Se isto e isto e isto e aquilo, como é que tu farias?” A música é a página branca para descobrir aquilo que vai sair e depois falamos sobre o que é que resulta, o que é que não resulta e no espectáculo há muita improvisação e há também muita escrita.Entre os objectos marcantes está, por exemplo, uma bola de discoteca gigante com a qual vocês dançam.Sim, a primeira vez que utilizamos essa bola é uma bola que está suspensa, fez-nos pensar logo no tempo porque muitas vezes o que nos separa nos mundos é o tempo e o tempo é relativo e, às vezes, eu estou bloqueada. Às vezes, é ele que está bloqueado. Então, esta bola simboliza como um pêndulo ou então, numa altura também, como festa. Mas inicialmente foi como um pêndulo do tempo.Outro elemento marcante no espectáculo, que é muito visual, é quando a Aline aparece um enorme véu branco e depois você surge desse véu e também faz uma dança muito intimista. Quer falar-nos dessa escolha?A escolha do véu não surgiu assim há muito tempo. Antes, fazíamos sem o véu e os coreógrafos um dia disseram “Aline, tu já vens com um vestido de casamento, porque não assumir um verdadeiro véu e usar um enorme véu?” Começámos a explorar a partir daí e a imagem também é como um rio que passa de um mundo para o outro. É o Kim que o traz e sou eu finalmente que acabo por levá-lo embora.A criação do espetáculo também passou por Portugal. Como é que foi essa etapa? Sim, foi a primeira residência que fizemos, foi no Porto. Correu super bem, foi aí que surgiu a primeira música em que eu falo da minha avó, o músico foi a gravar pessoas no Porto, a música da cidade, os sons, e ficámos logo com uma nostalgia, um ambiente que ajudou imenso a construir o resto do espectáculoO espectáculo é também muito imersivo. A música e a sua voz estão muito presentes e também dá ritmo ao próprio espectáculo. Como é que foi escrever esses textos? Como é que foi essa composição? A primeira, quando eu falo da minha avó, eles perguntaram-me se já tinha perdido alguém. Eu disse que sim. “Tens memórias?” E daí começaram logo a gravar e eu comecei a falar da minha avó que tinha um pequeno terreno de terra batida numa outra parte. Perguntaram-me o que é um mundo futurista para mim e eu comecei também a divagar, a falar de por que é que nós vemos o mundo futurista sempre cinzento, porque é que nos filmes há sempre esta cor cinzenta e não colorida, porque é que é tudo direito, porque é que é tudo tão angular, pronto, estas questões que nós temos como ideia do futuro. Sim, foi basicamente isso.Esta peça, de certa forma, também simboliza o que é a saudade? Muito, muito, muito. Para mim, visto que eu já estou do outro lado - eu fui aquela que morreu - e o Kim ainda está presente no mundo. Quando eu vejo que não o consigo alcançar é como se eu tivesse a oportunidade mas que não lhe conseguisse tocar. Então isso faz-me uma frustração, uma saudade, e faz-me bem vê-lo, faz-me bem tocá-lo, sim, sim.E aqueles movimentos de boneca que se descompõe. Esses movimentos foram sugeridos pela Aline?Sim. Há um estilo no hip-hop que se chama o “poping” que é tudo o que é contração muscular, robot, também o “smurf” e eu agora pratico bastante. Então, quando eles me pediram para tentar ser alguém inanimado, veio facilmente essa boneca que se descompõe e que é estranha.A Aline Lopes formou-se no CDA do Algarve, depois no Conservatório Nacional de Dança de Lisboa  e no Ballet Junior em Genebra. Em 2013, entrou na companhia suíça 7273; participou numa peça do corógrafo português Marco Ferreira da Silva ; passou também na Companhia Instável no Porto. Também trabalhou com a coreógrafa suíça Maud Blandel – que apresenta um espectáculo no IN deste ano com a presença da bailarina portuguesa Ana Teresa Pereira. Agora, está no off de Avignon com esta peça da companhia francesa B21. O que representa para si Avignon?Todos os meus colegas me falavam de Avignon, eu estava bastante curiosa para saber o que é que era viver estes espectáculos. Assim, todos os dias, está a ser óptimo porque eu sinto a evolução do espectáculo, eu sinto a evolução da minha personagem, sinto a evolução também em todos nós, a euforia das ruas, o vender o espetáculo...Também “vendeu” na rua o espectáculo? Sim! A falar, não a dançar!E é a primeira vez no Festival de Avignon?É a primeira vez como bailarina, sim.

In this episode, we have the audio recording from our recent B21 Lunch Panel at the 2023 SBC Annual Meeting in New Orleans, LA. This discussion was hosted by B21's Nate Akin, with panelists: Al Mohler, Danny Akin, Juan Sanchez, J.D. Greear, and Jarrett Stephens. 

Jared, Allen, and Matt are joined by Dr. Bart Barber, president of the Southern Baptist Convention, about how God has been working in and through First Baptist Farmersville, why they support the Cooperative Program so generously and sacrificially, and what to expect in New Orleans for the SBC Annual Meeting.. Bart is set to be nominated for a second term at #SBC23––make plans to be there! That's all well and good and the oppo research folks can comb through as necessary, but the real goods here are at the end as we dig into some Blue Bell Dr Pepper Float. Bart Barber on B21: https://podcasts.apple.com/us/podcast/episode-136-interview-with-2023-sbc-presidential/id1441454363?i=1000614626252Bart's Nomination: https://www.baptistpress.com/resource-library/news/louisiana-pastor-to-nominate-barber-for-second-term-as-sbc-president/Make sure you are following us on Facebook: https://www.facebook.com/PotluckPodcastSBC

Goof en Goot brengen Elektrisch & Loodvrij Vliegen weer een héél klein stapje dichterbij. Mijmeren over het verstandshuwelijk KLM/Airbus, en de mokkende Verlaten Echtgenote Boeing op de achtergrond. Doen geheimzinnig over de nieuwe B21. En haast nostalgisch over diens oudoom B52. Tippen zèlfs in dat verband even MH17 aan. Verder: Hollands Vergane Glorie F27 en Hollands Springlevende Glorie Verhees D2. Luistert dus mensen, lùistert!

Big contracts are being let for new aviation systems. From the B21 and FLAA in the US, to FCAS and Tempest in Europe, 6th generation air platforms are all the rage in government investment decisions at the moment. Dr Justin Bronk wonders whether these can make a difference to a much more challenging environment than has been assumed in Western capitals. The airspace over Ukraine is a deadly environment. The air defence capabilities on both sides makes flying a precarious proposition for anyone who enters the realm of mutual denied airspace. This has significant implications for everyone from force designers and military planners, to infantry companies and cartographers. If stealth, penetration, and survivability have become the key facets to air power in high intensity conflict then – according to Justin – we can do more with older platforms provided we start to buy back some of the risk that has accumulated in air forces across Europe since the peace dividend was taken.

Prezydent Francji Emmanuel Macron mówi o gwarancjach bezpieczeństwa dla Rosji, kiedy nadejdzie czas rozmów pokojowych. Czy to właściwy kierunek dla Zachodu? “Putin wojny nie zakończy, jeśli będzie to dla niego oznaczało utratę twarzy” - przyznaje Witold Jurasz, ale słowa francuskiego prezydenta nazywa “niebezpiecznymi”. “Jeśli w tej postwojennej architekturze będzie komuś trzeba dać gwarancje bezpieczeństwa, to Ukrainie i państwom bałtyckim, i Polsce, i Rumunii, a nie Rosji, bo to Rosja jest agresorem” - podkreśla w “Raporcie międzynarodowym”, ale komentuje nie tylko propozycję płynącą z Paryża. Mówi też o taktyce Rosji, tempie walk na froncie, sytuacji w Iranie i nowym bombowcu, który zaprezentowały Stany Zjednoczone. Zwraca uwagę, że przewaga technologiczna USA nad Rosją w dziedzinie zbrojeń jest widoczna gołym okiem. “To jest już przewaga dwóch generacji” - podsumowuje. W kontekście Polski wspomina o usuwaniu z MSZ absolwentów Uniwersytetu MGIMO, wskazuje, jak poziom oczytania wpływa na poziom dyskusji i tłumaczy własną teorię, nazwaną roboczo “teorią matki Jurasza”. 

१) आता चीन-रशियाची खैर नाही! अमेरिकेनं बनवला B21 अदृश्य महाशक्तीशाली बॉम्बर २) टाटांचा अभिमान! महिलांना सर्वाधिक नोकरी देणाऱ्यांमध्ये पटकावले अग्रस्थान ३) 'स्वास्थ्यम ग्लोबल वेलनेस' उपक्रमात फिटनेस ट्रेनर सर्वेश शशी मार्गदर्शन करणारेत ४) गुगलचे सीईओ सुंदर पिचाई यांना पद्मभूषण पुरस्कार प्रदान ५) उमर खालिदसह दोन आरोपींची निर्दोष मुक्तता ६) आरे आंदोलक फालतू आणि बोगस! सुमीत राघवनचं वादग्रस्त ट्विट ७) नेमबाजीत १८ वर्षीय रुद्रांश पाटलीने इजिप्तमध्ये जिंकलं सुवर्ण ८) राज्यपालांविरोधात उदयनराजे आक्रमक, राष्ट्रपतींना लिहिलं पत्र  स्क्रीप्ट अँड रिसर्च - अमित उजागरे, निलम पवार

Chef Bruno_ 250K Donation / Pastathon Auction // Christmas Tree Inflation / Drought // Steve Gregory_ B-21 Stealth Raider Unveiled //GMA Secret Romance

Matt Wagner is going to surprise you. His energy and voice seemingly know no boundaries... at least not yet.Matt's voice is a new icon waiting for discovery and I'm so proud to be one of the first to spread his message of good musical news.I was fortunate to discover Matt through a business relationship, who simply sent me an email asking my professional opinion. Now, usually when one gets these emails, the performers are average at best, so I wasn't expecting much, but then I heard his new single, Sorry, and I about lost my mind.Perfect pop nuggets aside, this is the new thing. Your ears are on the cusp of making a new friend and I'm so glad Matt gave me the time to share his story with you.So, without further ado, let's jump on the call and make it happen. This is Matt Wagner, otherwise known as MNERVA, and this is Rockstar Superhero.Time Codes:2:00 Talking to Matt about the stories behind MNERVA5:00 Seeing the angles8:00 The work ethic is key11:00 Being in the middle of the pack14:00 What did I miss?17:30 Being into rap, soul, and R&B21:00 Tossing water on the fire24:20 Sometimes it doesn't land27:30 Excited about a certain song30:40 The first real fan of MNERVA34:00 Nirvana and Tobi Vail37:10 Making life happen40:40 Motley Crue's The Dirt44:20 Never changing and doing because we love it47:25 Releasing the music for others50:30 Average at best53:25 Capturing the perfect moment really quicklySubscribe to both shows here: https://bit.ly/3airCvhWanna be on the show? Go here: https://calendly.com/rockstarsuperheroThe Rockstar Superhero Podcast examines the personal lives and creative careers of your favorite classic rock artists. We are obsessed with understanding the inner workings of the music business and all that it takes to remain in the public eye for as long as possible. Join us as we pursue conversations with legends and legends in the making.The Rockstar Superhero Radicals podcast was created to connect you directly to people, professional and private, who have lived lives worth discussing and offer solutions to our listeners, one heart at a time. If you are seeking truth and purpose beyond yourself, the Radicals podcast is for you.Copyright 2022 Rockstar Superhero Podcast - All Rights ReservedBecome a supporter of this podcast: https://www.spreaker.com/podcast/rockstar-superhero--4792050/support.

In this episode, we feature the audio recording from our B21 Panel at SBC 2022 in Anaheim. B21's Jed Coppenger led this discussion which included the following panelists: Tom Ascol, Danny Akin, Juan Sanchez, Dana Hall McCain, Bart Barber, & Albert Mohler.

Aujourd'hui on se retrouve pour faire un foot au parc et discuter de notre sportive star préférée : Jess de Joue-la comme Beckham ! On l'avoue, on n'y connait rien en foot mais ça nous empêche pas de raconter l'histoire de la talentueuse Jesminder, tiraillée entre sa passion et les attentes de sa famille. Elle navigue à travers tout un tas d'entraînements et de matchs teintés de racisme et de sexisme, de queercoding (et queerbaiting ?), de saris, d'esprit d'équipe, de mensonges, et de Jade qui part en chanson plus vite que vous n'ayez le temps de dire Vengabus. Merci à Jayhan (@JayhanOfficial) pour les super intro et outro ! Tu peux nous suivre sur Twitter et Instagram : @codexespod et aussi nous laisser une note et un commentaire sympa si tu veux. Force et amour, et amitié, respect, foot 2 rue. Ressources : - « Bend It Like Beckham Could Have Been Queerer, But It Still Aged Well », article (en anglais) de Deenah al-Aqsa sur la dimension queer de Joue-la comme Beckham. 2021 https://www.dispatchfmi.com/single-post/bend-it-like-beckham-could-have-been-queerer-but-it-still-aged-well - « Bend it Like Beckham: it's Time for a Lesbian Sequel », article (en anglais) de AJ sur la potentielle suite à Joue-la comme Beckham. 2021 https://afterellen.com/bend-it-like-beckham-its-time-for-a-lesbian-sequel/ - Wii Sports Theme de Kazumi Totaka, morceau de la BO de Wii Sports joué pendant l'épisode. - Inner Smile de Texas, morceau de la BO de Joue-la comme Beckham joué à la fin de l'épisode. - Putt Sardaran Da de B21, morceau de la BO de Joue-la comme Beckham joué à la fin de l'épisode.

In this episode, Nate Akin begins a new B21 series on Past SBC Presidents. He talks with Baptist History Prof. Eric Smith about first SBC President W.B Johnson. 

Jaký má život člověka smysl? každý z nbás se ptá podobné otázky: Proč existuje člověk? Proč existuju já? Proč mi život nedává smysl? Odpovědi aspoň na některé můžeme najít v Bibli - více v Bedřichově kázání. Smyslem života člověka je být zástupcem Boha na zemi, konkrétně - dávat život a kultivovat svět kolem sebe. „Tehdy Bůh řekl: „Učiňme člověka k našemu obrazu, podle naší podoby! Ať panují nad mořskými rybami, nad nebeským ptactvem, nad dobytkem, nade vší zemí i nad veškerou havětí lezoucí po zemi.“ Bůh stvořil člověka ke svému obrazu, k obrazu Božímu stvořil jej: jako muže a ženu stvořil je. A Bůh jim požehnal. Bůh jim řekl: „Ploďte a množte se, naplňte zem, podmaňte si ji a panujte nad mořskými rybami, nad nebeským ptactvem i nad každým živočichem lezoucím po zemi.“ Bůh také řekl: „Hle, dal jsem vám všechny byliny vydávající semeno na celém povrchu země i každý strom, na němž je ovoce vydávající semeno. To vám bude za pokrm. Také veškeré polní zvěři, všem nebeským ptákům i všemu, co leze po zemi, zkrátka všemu, co má v sobě život, jsem dal za pokrm všechny zelené byliny“ – a stalo se. Bůh viděl všechno, co učinil, a hle, bylo to velmi dobré! Byl večer a bylo ráno, den šestý.“ ‭‭Genesis‬ ‭1:26-31‬ ‭B21‬‬

In this episode, B21's Nate Akin delivers a short talk on Baptist Cooperation and then interviews Pastor Steven Carne about how they associated to plant a church.

In this episode, Nate Akin interviews B21's Jed Coppenger about prayer in the life of the church and his new book, “21 Days to Childlike Prayer”.

The Kingdom of Redonda and the Island of Barbuda in the Caribbean, news from the BBC World Service, KVOH Spanish ends on shortwave, Wavescan B21 schedule, DX reports from Australia and Bangladesh

The Kingdom of Redonda and the Island of Barbuda in the Caribbean, news from the BBC World Service, KVOH Spanish ends on shortwave, Wavescan B21 schedule, DX reports from Australia and Bangladesh

第8章 以色列求君王 1-3 撒母耳兩子不行正道－貪財收賄不正直 4-22 百姓向撒母耳求王 →A4-5 長老聚集向撒母耳求王治理國家，因撒母耳之子不行正道 －→B6 撒母耳求問神 －－→C7-9 上帝的回應－因百姓拒絕神作王而求王，要警戒百姓 －→B10-18 撒母耳對長老的警告－10-13 出人服事王；14-17 出物資服事王；18將會後悔 →A19-20 百姓堅持要立王，率領爭戰 －→B21 撒母耳向神禱告 －－→C22 上帝啟示－依從百姓， 結構亮光：撒母耳是位盡責，忠心的祭司，但是最大的問題是－沒有接班人，他的兒子拒絕行正道；這是撒母耳的失敗之處，他明明看見他的老師以利的兩個孩子的情況，但是卻無力，無法改變自己孩子生命不敬虔的情況！這兩個孩子應當成為撒母耳事奉的絆腳石，以至於當百姓提出立王這樣要求時，撒母耳不喜悅，但是他的兩個孩子卻堵住了他的口！事奉者要盡力教導以及為自己的孩子迫切禱告！ 當百姓向撒母耳要王時，以色列人求王的原因：1.撒母耳年紀大，2.兒子不遵行他的道，3.百姓羨慕鄰邦，4.厭棄神的領導權。表面的原因是期待有像外邦的君王治理百姓，可以帶領百姓爭戰20節，也有清楚的傳承(不像士師時代的混亂)；背後的動機上帝清楚指出－百姓要可以看見，甚至可以操控的君王來作王，而不要看不見的耶和華作王！可見人的靈性真是需要不斷被提醒提升，雖然經歷7章宗教復興，全以色列人心歸向神，戰爭得勝，但是仍然不以神作王，這是大問題！ 撒母耳提醒百姓君王制度的代價－要服事君王，提供人力，提供物資，來服事本來也是弟兄的君王，給予君王極高的權力，也帶來極大的墮落與敗壞！ 鑰節：8:7 耶和華對撒母耳說：「百姓向你說的一切話，你只管依從，因為他們不是厭棄你，乃是厭棄我，不要我作他們的王， 這群百姓是剛剛經歷－以便以謝，剛剛經歷宗教復興，除去偶像，尊神為大的子民，但是他們卻選擇拒絕神作王，而要可以看見的弟兄來作王！這個背後就是厭棄神！ 信心的成長是過程，也需要不斷的進步，不可以停下腳步，而我們人生到底要倚靠甚麼？是看得見的人，還是看不見的神？是忠於神，還是忠於自己厭棄神？求主憐憫！ 百姓只看見軍事問題，政治問題，卻沒有看見這個背後是靈性的問題－對神不忠，不信任神，選擇相信自己！ －－－－－－－－－－－－－－－－ 講員： 貴格會合一堂 徐坤靖牧師 聖經之鑰-各卷書播放清單： https://thfc.pse.is/3epsdf 【聖經之鑰 相關資源】 YouTube： https://thfc.pse.is/3cfams 電子書： https://thfc.pse.is/3ccluu Powered by Firstory Hosting

第2章 波阿斯厚待路得 1-3路得到波阿斯的田中收取麥穗 4-7波阿斯與僕人的對話：問安，問起路得 8-14波阿斯與路得的對話 →A8-9波阿斯：吩咐不要離開，吩咐僕人保護 －→B10路得：感恩，我是外邦人卻蒙恩 →A11-12波阿斯：讚美她對婆婆的愛，勇敢，鼓勵她信靠神，得神賞賜 －→B13路得：感恩，我不及你的使女，卻蒙你安慰 →A14波阿斯：用餐時照顧 15-16波阿斯與僕人的對話：要求僕人格外照顧路得 17-23路得與婆婆對話 →17-18路得將收穫帶回家，22L大麥，並且把所剩的餅給婆婆 →19-22拿俄米詢問她在哪裡收取麥穗，提醒不要離開她的使女 －→A19婆婆問：在哪裡收麥 －－→B19路得：波阿斯 －→A20婆婆：他是至近親屬，願神賜福 －－→B21路得：波阿斯吩咐緊隨他的僕人 －→A22婆婆：不要離開他的田地 →23路得與波阿斯的使女同在，直到收完大小麥 結構亮光：這是一章被愛所包圍的經文！波阿斯雖富為大財主，但是他顧念每個微小的人，5看見一個小女子；他給路得極大的恩惠，答應長期的照顧8，給予水9與食物14；他甚至命令僕人多為路得留一些16，並且給她尊榮15；並且積極讚美路得的忠心良善11；並且給予他屬天的祝福12！這是一個男人(丈夫)應有的樣式！ 路得也有許多美麗的特質：2勇敢主動謀生；7,15非常殷勤積極，從早晨7到晚上17，幾乎沒有休息，只有坐一會，用完餐立刻又去工作！以至於收穫豐碩17！有高度的感恩，10看見自己是外邦人，不配得這樣的照顧；13看自己比不上波阿斯的使女，卻得著這樣的祝福；18顧念婆婆，把餅帶回去給婆婆吃，並且工作所得都給婆婆(不藏私房錢)；23頂級的順服，當婆婆教導後就完全順服聽從，這是女人(妻子、媳婦)應有的樣式！ 拿俄米也扮演稱職的婆婆，19主動關心工作情況，20信仰教育，教導媳婦神的屬性，22教導待人處事，如何謹慎生活，這是長輩應有的樣式！ 鑰節：2:12願耶和華照你所行的賞賜你。你來投靠耶和華以色列神的翅膀下，願你滿得他的賞賜。 波阿斯給路得許多幫助，而最重要的在於－給她上帝的祝福！這也是基督徒主管給員工的祝福，向外邦員工傳福音的一個榜樣！波阿斯一方面給予路得祝福－願神賜福；二方面鼓勵路得來投靠神，而經歷神給的賞賜！這是我們可以給人最偉大的福氣！ －－－－－－－－－－－－－－－－ 講員： 貴格會合一堂 徐坤靖牧師 聖經之鑰-各卷書播放清單： https://thfc.pse.is/3epsdf 【聖經之鑰 相關資源】 YouTube： https://thfc.pse.is/3cfams 電子書： https://thfc.pse.is/3ccluu Powered by Firstory Hosting

Die Bundestagswahl 2021 steht an. Ich spreche mit dem Bundesvorsitzenden der Partei Mensch Umwelt Tierschutz (Tierschutzpartei) über die Partei, das Wahlprogramm uvw. Sponsor dieses Podcast ist “Athletic Greens“. Als Hörer*In meines Podcasts erhältst du zu Deinen Athletic Greens einen Jahresvorrat an Vitamin D3 und 5 Travel Packs kostenlos dazu. Das Angebot findest du unter www.athleticgreens.com/lustaufvegan

In this episode, we have Alex Gladstein, Chief Strategy Officer at Human Rights Foundation, and Oslo Freedom Forum with host Nitin Agarwal, B21. A lot to unpack in this episode as Alex Gladstein shares light on why Bitcoin is the future, not anything else. Bitcoin securing Financial Freedom in Authoritarian Regimes, and we also discuss the Trojan Horse Effect on how Bitcoin is spreading everywhere! Alex Gladstein's Socials: Twitter: https://twitter.com/gladstein Web: https://hrf.org/ Web: https://oslofreedomforum.com/ Stay updated with The Desi Crypto Show: Web: http://b21.io Twitter: https://Twitter.com/B21TV Discord: https://discord.gg/DpXJWurHgh -- 00:00 Introduction 00:37 Bitcoin is future, not Blockchain or Crypto 01:04 Alex Gladstein's work in Human Right 02:16 Alex's involvement with Bitcoin & How Bitcoin helps with financial freedom 05:04 How is Bitcoin helping people in Troubled Economies & Authoritarian Countries? 08:00 How the Media covers Bitcoin, mostly in a negative light. 10:54 Is Bitcoin being used to evade taxes? Is that possible? 14:51 Sanctions on Country, Smart Sanctions on Individuals, Trojan Horse Effect 19:51 Fees are high, speed is slow how does Bitcoin compare with traditional money system? 23:08 Is Bitcoin hard to use in the Authoritarian Countries? 24:50 BOLD Prediction about Bitcoin 25:54 Bitcoin vs other coins 26:43 Closing.

[新闻看点] 基辛格籲美中對話；王岐山要美負全責？！故意洩密，中共有機器殺手；核戰逼近中俄朝伊威脅大；美無人潛艇巡航，B21先亮相；存百萬剩1元，劇情狗血有內情？

Fresh off securing 1 Billion pesos in retail deposits after their 1st month, Greg Krasnov, the Founder and CEO of Tonik Bank, joins us for our season finale of Hustleshare. Greg will share his early hustles in finance and tech that led him into private equity and finance that ultimately led him to get a bank that he founded in Ukraine. He will also share how he helped build fintech companies in Southeast Asia through Forum and how he decided to go all in on creating a digital bank in the Philippines. Greg will also share how they were able to capitalize on opportunities in the Philippine market and get great traction fast en route to them raising $17 Million for their Pre-Series B funding. This episode brought to you by B21. For show notes, go to hustleshare.com Download Kumu now: https://podlink.co/kumu-hustleshare Hustleshare is powered by Podmetrics

B21 community is a place where like minded people share ideas, knowledge and engage in discussions around cryptos

Yang Yang Zhang, Managing Director of Xendit Philippines, joins us in this episode to share how she is leading Southeast Asia's biggest payment solutions provider in the Philippines. She will also share her amazing career in tech and creating products and infrastructure. Yang Yang will also share how she joined Xendit and how she is leading their expansion in the Philippines in the middle of a pandemic while applying lessons from her previous hustles like how a startup can attain and measure product-market fit. This episode brought to you by B21. For show notes, go to hustleshare.com Hustleshare is powered by Podmetrics

Agnes Gervacio, CEO of MDI Novare, joins us in this episode to share how she leads one of the biggest and oldest tech companies in the Philippines. She will also share her journey in her illustrious career and how she overcame stereotypes as a woman while she led multiple tech corporations. She will also share great career advice on how employees can break through challenges to climb up the corporate ladder and become a C-Suite executive by surrounding yourself with the right people. This episode brought to you by B21. For show notes, go to hustleshare.com Hustleshare is powered by Podmetrics

In this episode, Nate Akin, Jed Coppenger, and Ronnie Parrott discuss the upcoming Southern Baptist Convention and answer questions posed to B21. These questions cover important potential business, resolutions, motions, elections, and more.

Nitin Agarwal is the Co-Founder and CEO of B21, a global crypto platform for buying and managing crypto assets. In this conversation, we discuss:- What is B21?- Bringing the next 100mm people into crypto - Crypto Relief Fund for Covid-19 in India - Advice to crypto rookies - Partnering with Celsius and Alex Mashinsky - International Cards- Scaling worldwide  - Crypto in Gibraltar  B21Website: b21.io Twitter: @B21Official Telegram: @B21Official Nitin AgarwalTwitter: @nityn ------------------------------------------------------------------------CoinPokerCoinPoker is a revolutionary blockchain technology-based platform that was developed by an ambitious team of poker lovers.CoinPoker uses USDT as the main in-game currency and CHP as in-game fuel, offering all benefits of the crypto world alongside. CoinPoker also features instant and secure transactions using USDT, ETH, BTC or CHP tokens and no KYC.CoinPoker users get huge promotions, as they give away thousands in fiat value each week. CHP is the currency of the CoinPoker economy providing players with exclusive benefits and supports future developments delivered to the CoinPoker community.Play some hands, collect wins, and cash out in Bitcoin, Ethereum, or CHP!Twitter: @CoinPoker_OFFWebsite: coinpoker.comTelegram: @officialcoinpoker

What's your favourite Punjabi song?In 2015, I recorded a show focusing on my ten favourite Punjabi tracks to celebrate my thirtieth birthday. It features a little bit of Surinder Shinda, Bindrakhia, B21, and, of course, the almighty Chamkila. And there's a hint of a future mid-life crisis.